TMO - Thermo Fisher Scientific, Inc. -  [ ]

Ticker Details
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific Inc is a healthcare company. It offers analytical instruments, laboratory equipment, software, services, consumables, reagents and chemicals.
IPO Date: January 2, 1990
Sector: Healthcare
Industry: Life Sciences Tools and Services
Market Cap: $194.99B
Activated in VL: True
Average Daily Range
Avg Daily Range: $2.41 | 1.08%
Avg Daily Range (30 D): $8.12 | 1.69%
Avg Daily Range (90 D): $8.06 | 1.66%
Institutional Daily Volume
Avg Daily Volume: 1.83M
Avg Daily Volume (30 D): 1.71M
Avg Daily Volume (90 D): 1.73M
Trade Size
Avg Trade Size (Sh.): 89
Avg Trade Size (Sh.) (30 D): 29
Avg Trade Size (Sh.) (90 D): 28
Institutional Trades
Total Institutional Trades: 38,832
Avg Institutional Trade: $12.02M
Avg Institutional Trade (30 D): $48.7M
Avg Institutional Trade (90 D): $43.43M
Avg Institutional Trade Volume: .06M
Avg Institutional Trades (Per Day): 6
Market Closing Trades
Avg Closing Trade: $56.47M
Avg Closing Trade (30 D): $226.59M
Avg Closing Trade (90 D): $179.04M
Avg Closing Volume: 171.98K
 
News
Jul 6, 2026 @ 8:49 AM
Environmental DNA Market Set to Surge to USD 5.61 ...
Source: Researchandmarkets.Com
Jul 3, 2026 @ 10:48 AM
Molecular Biology Enzymes, Reagents and Kits Marke...
Source: Sns Insider
Jul 3, 2026 @ 9:12 AM
Global Single-use Bioreactors Market Forecast to S...
Source: Researchandmarkets.Com
Jul 3, 2026 @ 8:47 AM
Unlocking Growth in the Sweden Flu Market: The Ris...
Source: Researchandmarkets.Com
Jul 3, 2026 @ 8:43 AM
Global Pharmaceutical Filtration Market to Double ...
Source: Researchandmarkets.Com
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $18.22 $4.44 $5.22
Diluted EPS $18.19 $4.43 $5.21
Revenue $45.2B $11.01B $12.22B
Gross Profit
Net Income / Loss $6.87B $1.66B $1.97B
Operating Income / Loss $7.89B $1.86B $2.26B
Cost of Revenue
Net Cash Flow $-1198M $-6676M $7.87B
PE Ratio